Leerink Partnrs Forecasts Lower Earnings for CVS Health

CVS Health Co. (NYSE:CVS) – Research analysts at Leerink Partnrs dropped their Q4 2024 earnings estimates for shares of CVS Health in a research report issued on Wednesday, December 18th. Leerink Partnrs analyst M. Cherny now anticipates that the pharmacy operator will earn $0.98 per share for the quarter, down from their previous estimate of $1.24. The consensus estimate for CVS Health’s current full-year earnings is $5.32 per share. Leerink Partnrs also issued estimates for CVS Health’s Q2 2025 earnings at $1.66 EPS.

Several other equities analysts have also recently weighed in on CVS. TD Cowen increased their price objective on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. Mizuho decreased their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Evercore ISI boosted their price objective on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Finally, Royal Bank of Canada dropped their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $69.12.

CVS Health Stock Up 0.2 %

CVS Health stock opened at $44.25 on Monday. The stock has a market cap of $55.68 billion, a PE ratio of 11.23, a price-to-earnings-growth ratio of 0.85 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a fifty day moving average of $55.80 and a 200 day moving average of $58.10. CVS Health has a one year low of $43.56 and a one year high of $83.25.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the company posted $2.21 earnings per share.

Institutional Investors Weigh In On CVS Health

A number of hedge funds have recently bought and sold shares of the business. Garland Capital Management Inc. grew its stake in shares of CVS Health by 0.3% in the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock worth $3,591,000 after buying an additional 160 shares in the last quarter. Sound Income Strategies LLC lifted its holdings in shares of CVS Health by 7.2% in the 3rd quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator’s stock valued at $151,000 after acquiring an additional 162 shares during the last quarter. Hexagon Capital Partners LLC increased its stake in CVS Health by 3.5% during the third quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator’s stock worth $331,000 after acquiring an additional 178 shares during the last quarter. Bruce G. Allen Investments LLC raised its position in CVS Health by 13.1% during the third quarter. Bruce G. Allen Investments LLC now owns 1,681 shares of the pharmacy operator’s stock valued at $106,000 after purchasing an additional 195 shares during the period. Finally, HHM Wealth Advisors LLC boosted its holdings in shares of CVS Health by 11.9% in the 2nd quarter. HHM Wealth Advisors LLC now owns 1,886 shares of the pharmacy operator’s stock worth $111,000 after purchasing an additional 200 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.